CANC icon

Tema Oncology ETF
CANC

25.40 USD
-0.76
2.91%
At close Jun 13, 4:00 PM EDT
1 day
-2.91%
5 days
-0.86%
1 month
10.58%
3 months
1.97%
6 months
0.87%
Year to date
3.93%
1 year
-8.83%
5 years
1.32%
10 years
1.32%
0
Funds holding %
of 7,296 funds
–
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

133% more funds holding

Funds holding: 3 [Q4 2024] → 7 (+4) [Q1 2025]

21.67% less ownership

Funds ownership: 26.85% [Q4 2024] → 5.18% (-21.67%) [Q1 2025]

70% less capital invested

Capital invested by funds: $13.2M [Q4 2024] → $3.91M (-$9.25M) [Q1 2025]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for CANC.

See Analyst Rankings

Financial journalist opinion

Positive
ETF Trends
6 months ago
Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.
Disruptive Theme of the Week – Breakthroughs in Medicine
See News Rankings
Charts implemented using Lightweight Charts™